Croatia

The 5th Meeting of the Human Glycome Project

IgG glycome as a biomarker and effector of CVD risk

Join us as we continue our quest to better understand glycans: their genetic regulation & evolution, their role in health, disease, therapy, and more!

technical paper

Role of ACPA glycosylation in rheumatoid arthritis

Antigen-specific Fab profiling of autoantibody repertoires in RA

Exploration of AI model’s capabilities for producing insights from glycan biomarkers

How can we change the IgG glycome composition

Glycans in Schistosoma haematobium

Establishment of a new detection method for polysialic acid in biological samples

Mining the information contained in the IgG glycome

GlyCoDA: Compositional data analysis for disease risk prediction using glycans

Dynamic Strategies for Development of Host-Responsive Medical Devices

Cell Surface N-Glycoproteomics to Map the Colorectal Cancer Glycome

https://d3smihljt9218e.cloudfront.net/transcript/89081/subtitle/3eba12ac95fd0a56371d7cb24b121169.vtt

English (automatic)

Downloads

Next from The 5th Meeting of the Human Glycome Project

Role of ACPA glycosylation in rheumatoid arthritis

Similar lecture

How can we change the IgG glycome composition

.css-70qvj9{display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;}Downloads

Next from The 5th Meeting of the Human Glycome Project

Role of ACPA glycosylation in rheumatoid arthritis

Similar lecture

How can we change the IgG glycome composition

Downloads